Research
FORUM TRANSCRIPT

Berkeley Lights – Cell & Gene Therapy Development – 20 July 2021

  • Public Equity
  • Healthcare
  • North America
PREMIUM

Specialist

Former product manager at Berkeley Lights Inc

Agenda

  • Cell and gene therapy trends and developments
  • Berkeley Lights' (NASDAQ: BLI) competitive positioning vs AbCellera (NASDAQ: ABCL)
  • Cost control, quality and efficiency across technologies
  • H2 2021 outlook and potential commercialisation capabilities

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo